OMB is approving this information collection request for a period of six months during which time the agency will request approval to extend or revise the collection if the agency seeks to continue the information collection activity beyond the period approved under this action.
Previous terms continue. Approved with the understanding that changes in data elements will be submitted as nonsub changes and larger revisions, including methodology, methods of administration, or the addition of conditions will be submitted as revisions. CDC will work with their OIRA desk officer to brief upcoming changes and determine the appropriate pathways for submission.
Inventory as of this Action
Requested
Previously Approved
07/31/2020
4 Months From Approved
04/30/2022
7,948
0
7,288
20,045
0
19,578
851,619
0
830,600
The National Notifiable Diseases Surveillance System is the nation's public health surveillance system used to monitor the occurrence and spread of nationally notifiable conditions. The NNDSS facilitates the submission and aggregation of case notification data voluntarily submitted to CDC from 60 jurisdictions including health departments in every U.S. state, New York City, Washington DC, 5 U.S. territories, and 3 freely associated states. It is the official source of statistics in the U.S. for nationally notifiable conditions and CDC is the sole repository for these national, population-based data. 2019 novel coronavirus (2019-n-CoV) to the National Notifiable Diseases Surveillance System (NNDSS). NNDSS is the nationâs public health surveillance system used to monitor the occurrence and spread of nationally notifiable conditions as well as some conditions under national standardized surveillance.
Much remains unknown about the etiology, transmissibility, and characteristics of 2019-nCoV, and as demonstrated by previous outbreaks of SARS-associated coronavirus and Middle East Respiratory Syndrome (MERS), novel coronaviruses provide a significant threat of spreading among humans and causing severe illness. Early detection and intervention remains the best way to control the spread of novel infectious diseases, and complying with normal clearance timelines for 2019-nCoV would delay effective detection and control efforts, potentially threatening public health if this novel, poorly understood virus proves to be transmissible among humans, 2019 novel coronavirus (2019-n-CoV) to the National Notifiable Diseases Surveillance System (NNDSS).
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
States - One-time SO/GI Survey
OMB Emergency Review Memo_nCov 0728_1.18.20.pdf
OMB_0920-0728_Change Request_Plague Tularemia_06212019.doc
Att 20 - Burden Table Calculations.xlsx
SSA_nCoV to NNDSS_1.22.2020 CLEAN.docx
Cities - Responses for 180 Days